Coronary Disease
Conditions
Brief summary
Prospective Internet-Registry, Postmarketing-Surveillance, Registration and Follow-up of patients after Multi-Link VISION™ - Stent Implantation
Detailed description
A Non-Randomized prospective evaluation of the Multi-Link Rx Vision TM Coronary Stent System in the treatment of patients with De novo native coronary artery lesions
Interventions
Patients who have diabetes and/or complex lesions and who have had a Multilink Vision™ Stent placed.
Sponsors
Study design
Eligibility
Inclusion criteria
* Women and Men Age \>18 years, Intention to treat all stenosis with Multi-Link VisionTM Stents, documented patient consent
Exclusion criteria
* No Multi-Link Vision™ Stent implanted, life expectation \>9 M, cardiogenic shock, STEMI, NSTEMI or unstable angina pectoris with pathologic markers within the last 48 hours, intolerance of Clopidogrel/ Tiklopidin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TVF | 9 months |
Secondary
| Measure | Time frame |
|---|---|
| Mode of death | — |
| Time to first MI | — |
| TVR | — |
| CABG | — |
Countries
Germany